GlobeNewswire 2019-09-04 Summit Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 2019-08-01 Summit Therapeutics to Present at the Canaccord Genuity Growth Conference
GlobeNewswire 2019-07-17 Summit Highlighted Potential of SMT-571 to Combat the Rising Global Health Threat of Gonorrhoea at S...
GlobeNewswire 2019-07-09 Summit’s DDS-04 Enterobacteriaceae Programme Demonstrates In Vivo Efficacy in Sepsis and Pneumonia
GlobeNewswire 2019-06-20 Summit to Present on Pipeline and Strategy for its New Classes of Antibiotics at ASM Microbe 2019
GlobeNewswire 2019-06-18 Increased BARDA Award and Option Exercise
GlobeNewswire 2019-06-12 Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended 3...
GlobeNewswire 2019-06-05 Notice of First Quarter Results
GlobeNewswire 2019-04-16 Detailed Research: Economic Perspectives on Patterson-UTI Energy, Take-Two Interactive Software, DXC...
GlobeNewswire 2019-04-14 Summit Presents In Vivo Proof of Concept Data for New Mechanism Antibiotics Targeting Enterobacteria...
GlobeNewswire 2019-04-03 Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae
GlobeNewswire 2019-04-02 Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference
GlobeNewswire 2019-03-29 Award of Share Options
GlobeNewswire 2019-03-27 Final Results
GlobeNewswire 2019-03-25 Notice of Results
GlobeNewswire 2019-03-18 Summit Therapeutics to Present at Upcoming Conferences
GlobeNewswire 2019-03-14 Summit Highlights Use of Discuva Platform in Identifying New Mechanism Antibiotics against Neisseria...
GlobeNewswire 2019-02-25 Summit’s SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numer...
GlobeNewswire 2019-02-19 New Research Coverage Highlights Global Payments, Tableau Software, Summit Therapeutics, Utah Medica...
GlobeNewswire 2019-02-13 Summit Doses First Patient in Phase 3 Clinical Trials of Precision Antibiotic Ridinilazole for C. Di...
GlobeNewswire 2019-02-08 Summit Therapeutics to Present at the BIO CEO & Investor Conference
GlobeNewswire 2019-01-10 Completion of $25 million subscription
GlobeNewswire 2018-12-18 AVROBIO, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires
GlobeNewswire 2018-12-17 Proposed Subscription to Raise $25m and Notice of General Meeting
GlobeNewswire 2018-12-17 Summit Therapeutics Announces Departure of Chief Financial Officer